Free Trial
→ We recommended Nvidia in 2016, now we’re recommending this… (From Porter & Company) (Ad)

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

→ Financial Prophecy (From Porter & Company) (Ad)

Should you invest $1,000 in Denali Therapeutics right now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.4645 of 5 stars		$24.38-0.2%N/A-8.83Moderate Buy$38.90
Ultragenyx Pharmaceutical (RARE)
4.6424 of 5 stars		$46.80+0.9%N/A-7.23Moderate Buy$87.46
Sarepta Therapeutics (SRPT)
4.914 of 5 stars		$111.11+0.2%N/A88.89Buy$181.33
Pfizer (PFE)
5 of 5 stars		$25.14+0.8%6.68%33.97Moderate Buy$32.92
Exelixis (EXEL)
4.7895 of 5 stars		$34.81+0.5%N/A22.31Moderate Buy$31.44
Moderna (MRNA)
4.6292 of 5 stars		$38.33+3.8%N/A-6.59Hold$84.00
United Therapeutics (UTHR)
4.5228 of 5 stars		$369.42+1.4%N/A16.22Moderate Buy$370.86
Biogen (BIIB)
4.8648 of 5 stars		$157.27+0.8%N/A14.21Moderate Buy$257.20
Sanofi (SNY)
2.8245 of 5 stars		$47.94+0.3%3.09%24.46Moderate Buy$57.50
Eli Lilly and Company (LLY)
4.9913 of 5 stars		$748.59-0.6%0.69%80.93Moderate Buy$1,007.94
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

With revenue growth nearing 95%, margins widening, and earnings soaring 111%, this might be NVIDIA's most impressive performance yet.

Related Videos

How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide
NVIDIA Nears All-Time Highs: How High Can This AI Leader Climb?
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines